Company Filing History:
Years Active: 2016-2019
Title: Kelly D McCall - Innovator in Cancer Treatment Research
Introduction
Kelly D McCall is an inventor based in Shade, Ohio, who is focused on developing methods and compositions for the treatment of various types of cancer. Her research highlights the significant role of chronic inflammation in cancer development, particularly through the proinflammatory cytokine IL-6. This cytokine is crucial for the activation of STAT, a key regulator involved in cancer growth, survival, metastasis, immune evasion, and angiogenesis.
Latest Patent Applications
Kelly D McCall has submitted a patent application titled "METHODS AND COMPOSITIONS FOR THE TREATMENT OF MALIGNANT MELANOMA, BREAST, PROSTATE, COLON, PAPILLARY THYROID AND PANCREATIC CANCER." This application discusses the implications of increased IL-6 and Stat-3 in various cancer cells, emphasizing the importance of TLR3 signaling in tumor growth. The application also presents a novel inhibitor, 5-phenylmethimazole (C10), which has shown promise in decreasing markers associated with cancer cell growth and migration.
Conclusion
Kelly D McCall's innovative research aims to address critical challenges in cancer treatment, focusing on the mechanisms that drive tumor growth and the potential for new therapeutic approaches. Her work represents a significant contribution to the field of oncology and highlights the importance of understanding inflammatory processes in cancer development.